Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01181206
Other study ID # TUM-Chir-002/2010
Secondary ID
Status Completed
Phase N/A
First received August 11, 2010
Last updated September 19, 2017
Start date August 2010
Est. completion date February 2014

Study information

Verified date December 2012
Source Technische Universität München
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

BaFo is a prospective, double-blinded randomized controlled clinical trial that assesses the numbers of surgical site infections in two different techniques of covering the abdominal wall in laparotomies. Standard covering with woven swabs is compared to a novel, approved 3M™ Steri-Drape™ Wound Edge Protector.


Recruitment information / eligibility

Status Completed
Enrollment 516
Est. completion date February 2014
Est. primary completion date August 2013
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Ability to sign the informed consent

- Patients older than 18 years

- Abdominal operations with longitudinal / cross section with clean wounds, clean-contaminated wounds or contaminated wounds (cdc-definitions of surgical wound infections)

Exclusion Criteria:

- Pregnant or lactating women

- Revision Operations

- Operations with dirty or infected wounds (CDC definition of surgical wound infections)

- Laparoscopic operations

- Small operations without longitudinal- / cross-section e.g. appendectomy

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Intervention Arm 1: Covering with approved abdominal 3M™ Steri-Drape™ Wound Edge Protector Intervention Arm 2: Covering with standard woven swabs


Locations

Country Name City State
Germany Department of Surgery and Institute of Statistics Klinikum rechts der Isar der Technischen Universität München München Bavaria

Sponsors (1)

Lead Sponsor Collaborator
Technische Universität München

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Surgical site infections 3 years
Secondary Body-Temperature during Operation 3 years